divian@aexcap.com
Divian founded AEX Capital in July 2017. Prior to this, he held the position of Global Chief Business Officer and CEO (SA) at Cipla Biotech (a subsidiary of Cipla Ltd – India). He is a proven business leader with 18 years international experience in executive management, business development, deal making, corporate and legal strategy, most of which is in the pharmaceutical industry. He has managed executive teams and has concluded deals that span multiple geographies, which include M&A transactions, Strategic Alliances, Partnering, Government Affairs, Licensing and Joint Ventures.
His proficiencies in identifying and evaluating potential investment opportunities and structuring transactions enable him to develop strategic business relationships, resulting in successful mergers, acquisitions and disposals in sectors ranging from pharmaceutical to biotech, energy and manufacturing.
Previously he was the Chief Business Development Officer at Cipla Medpro, Group Senior Executive (Senior VP) New Business Development and Legal at Aspen Pharmacare, Executive(VP) Strategy & Legal at Aspen Pharma, Commercial Director at Brimpharm (subsidiary of Aspen) and Group Legal Manager at Adcock Ingram and business consultant. Divian has a degree in commerce (B Com-Finance), a post graduate law degree (LLB) and a certificate in corporate finance. He is an admitted attorney of the High Court of South Africa (non-practicing).